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Communication 
Constitutive Ion Fluxes and 
Substrate Binding Domains of 
Human Glutamate Transporters* 
(Received for publication, March 22, 1995, and in revised form, 
June 1, 1995) 
Robert J. Vandenberg:j:§, Jeffrey L. Arriza, 
Susan G. Amara:j:, and Michael P. Kavanaugh'll 
From the Vollum Institute and :j:Howard Hughes 
Medical Institute, Oregon Health Sciences University, 
Portland, Oregon 97201 
Application of L-glutamate activates ionic currents in 
voltage-clamped Xenopus oocytes expressing cloned human 
excitatory amino acid transporters (EAATs). However, even 
in the absence of L-glutamate, the membrane conductance 
of oocytes expressing EAAT1 was significantly increased 
relative to oocytes expressing EAAT2 or control oocytes. 
Whereas transport mediated by EAAT2 is blocked by the 
non-transported competitive glutamate analog kainate <.K. 
= 14 #JM), EAAT1 is relatively insensitive <X. > 3 IDM). Sub-
stitution of a block of 76 residues from EAAT2 into EAAT1, 
in which 18 residues varied from EAAT1, conferred high 
affinity kainate binding to EAAT1, and application ofkain-
ate to oocytes expressing the chimeric transporter blocked 
a pre-existing monovalent cation conductance that dis-
played a permeability sequence K+ > Na+ > Li+ » cho-
line+. The results identify a structural domain of glutamate 
transporters that influences kainate binding and demon-
strate the presence of a constitutive ion-selective pore in 
the transporter. 
Transport of L-glutamate in the central nervous system and 
periphery is mediated by a family of membrane proteins pos-
tulated to contain from 6 to 10 transmembrane domains (for 
review, see Ref. 1). An important goal in understanding the 
molecular basis of transporter function is the identification of 
the structural domains involved in substrate recognition and in 
the formation of the pore or conduction pathway through which 
amino acids and other ions pass. Glutamate uptake is accom-
panied by an influx of sodium ions and an effiux of potassium 
and hydroxyl ions (2-5). Voltage clamp recording from cells 
with sufficiently high transporter density can be used to meas-
ure membrane currents associated with glutamate uptake. A 
stoichiometry proposed for uptake involves co-transport of 
2Na+:1Glu- with countertransport of 1 K+ and 1 OH-, result-
ing in translocation of one net positive charge (5). However, 
recent studies of a cloned human glutamate transporter have 
* This work was supported by a Hitchings award from the Burroughs 
Wellcome Fund, the Howard Hughes Medical Institute, and National 
Institutes of Health Grants NS33273 (to S. G. A.) and NS33270 (to 
M.P. K.). The costs of publication of this article were defrayed in part 
by the payment of page charges. This article must therefore be hereby 
marked "advertisement" in accordance with 18 U.S.C. Section 1734 
solely to indicate this fact. 
§ Supported by fellowships from Sydney University Medical Founda-
tion and the Human Frontiers of Science Program. Current address: 
Dept. of Pharmacology, University of Sydney, Sydney, NSW 2006, 
Australia. 
'11 To whom correspondence should be addressed. Tel.: 503-494-4601; 
Fax: 503-494-2285. E-mail: kavanaug@ohsu.edu. 
THE JOURNAL OF BIOLOGICAL CHEMISTRY 
Vol. 270, No. 30, Issue of July 28, pp. 17668-17671, 1995 
© 1995 by The American Society for Biochemistry and Molecular Biology, Inc. 
Printed in U.S.A. 
demonstrated that the quantity of charge translocated with 
glutamate is voltage-dependent (6). This variable charge stoi-
chiometry occurs as a consequence of an additional current 
arising from a thermodynamically uncoupled chloride flux ac-
tivated by transporter substrates (7, 8). Different transporter 
subtypes exhibit intrinsic differences in the magnitude of the 
chloride flux relative to flux of glutamate (7). 
In addition to differences in ion conduction properties, phar-
macological differences exist between the human excitatory 
amino acid transporter subtypes. Many compounds that inhibit 
radiolabeled glutamate transport (e.g. serine 0-sulfate, 
L-trans-pyrrolidine-2,4-dicarboxylic acid, L-cysteic acid, and D-
aspartate) also induce inward currents, suggesting that they 
act as competitive substrates for transport (9). In contrast, 
kainate and dihydrokainate, two conformationally restricted 
glutamate analogues (10), selectively and competitively block 
transport of glutamate by the EAAT21 subtype but are not 
themselves transported. EAAT1 and EAAT3 are insensitive to 
these compounds (Ki > 3 mM) (9). Schild analysis of the inhi-
bition of EAAT2 by kainate has demonstrated that the Kd is 
relatively voltage-independent, which suggests that kainate 
binds to an external site on the transporter outside the mem-
brane electric field ( 6). The competitive action of kainate with 
respect to glutamate (9) and similar voltage independence of 
the Km for glutamate activation2 suggest that kainate may 
interact with EAAT2 at the same site in the outer pore of the 
transporter where glutamate first binds. 
Studies on various cloned sodium-dependent transporters 
have demonstrated the presence of substrate-independent cur-
rents (11-14), suggesting that these carriers possess intrinsic 
pores through which ions pass (for review see Ref. 15). Identi-
fication of differences in pore conduction properties between 
the transporter subtypes will facilitate identification of resi-
dues involved in forming the pore structure. In this study we 
demonstrate that EAAT1, but not EAAT2, allows substrate-
independent ion fluxes. We have constructed a chimeric trans-
porter that mediates a glutamate-independent conductance 
blocked by kainate, thereby identifying a domain involved in 
substrate binding and allowing analysis of the voltage depend-
ence and ionic selectivity of this substrate-independent 
current. 
EXPERIMENTAL PROCEDURES 
Construction of a Chimeric Transporter-An in vivo recombination 
procedure (17) was used to construct chimeric glutamate transporters. 
The EAAT1 and EAAT2 cDNAs were cloned in tandem into the pCMV 
plasmid (9) with a unique Xbai site between the cDNAs. The tandem 
construct was linearized with Xbai, and 100 ng of DNA was used to 
transform competent DH5a cells. Colonies were screened for plasmids 
that contained a single eDNA and sequenced to determine the junction 
sites (Sequenase, U. S. Biochemical Corp.). A number of plasmids were 
isolated, and all the chimeras generated using this method had junction 
sites within a highly conserved domain from serine 366 to glutamine 
415 (EAAT1 numbering). One of these chimeras contained an EAAT1 
sequence at the amino terminus and junctioned with EAAT2 after 
serine 366. An EcoRI site was incorporated into the EAAT2 segment in 
this chimera at a position corresponding to an endogenous EcoRI site in 
EAAT1 (residues 442-443), and this construct was used to generate a 
three-part chimera using a polymerase chain reaction-based strategy. 
Briefly, an antisense oligonucleotide incorporating silent base changes 
1 The abbreviations used are: EAATl, EAAT2, and EAAT3, human 
excitatory amino acid transporters 1-3; ,.,s, microsiemens. 
2 M. Kavanaugh, unpublished observations. 
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FIG. 1. EAATl mediates an uncoupled ion flux. A, current-voltage plots of oocytes 4 days following injection of equal amounts of eRN A 
encoding EAATl (open circles), EAAT2 (open squares), or uninjected controls (filled circles). Data points represent mean ± S.E. (n = 6). B, voltage 
dependence of glutamate-independent current in oocytes expressing EAAT1 obtained by subtraction of the mean current-voltage curve of 
uninjected oocytes from that of oocytes expressing EAATl. C, the amplitude of the uncoupled current in individual oocytes between 1 and 5 days 
following injection of EAATl cRNA (measured as the difference in chord conductance compared with matched control oocytes) is proportional to 
the level of expression of the transporter (measured as the amplitude of the current elicited by 300 IJ.M L-glutamate at -100 m V) in the same 
oocytes. 
to introduce the EcoRI site was paired with a sense oligonucleotide 
corresponding to the vector poly linker and used in a polymerase chain 
reaction with the chimera as template. The resulting product was 
subcloned into EAAT1, and the entire coding region was sequenced to 
confirm the structure of the construct. The three-part chimera, termed 
E1-2-1, was subcloned into pOTV for oocyte expression (9). 
Electrophysiological Recording-50 ng of capped eRN A transcribed 
with T7 polymerase from each of the eDNA constructs was injected into 
defolliculated stage V Xenopus oocytes. Two to seven days later trans-
port was measured by two-electrode voltage clamp recording, and ki-
netic analyses were performed as described previously (16). In experi-
ments involving ion substitution, sodium was partially replaced with 
equimolar choline, lithium, or potassium. The permeabilities of test 
ions relative to Na+ were determined from the shift in reversal poten-
tial, Ll. V, of the kainate-sensitive leak current induced by substitution of 
one-half the extemal sodium with ion X from a modified form of the 
Goldman-Hodgkin-Katz equation, PxfPNa = 2(exp(Ll.VF/RT))- 1. Mean 
shifts for each test ion were calculated by measurement of reversal 
potentials in 4-6 oocytes following measurement in control (ND96) 
solution. In experiments in which the chloride concentration was al-
tered, chloride was substituted with either gluconate or methane sul-
fonate. To avoid offset potentials, a 3 M KCllagar bridge was used to 
connect the bath to ground via a 3 M KCl reservoir containing a silver/ 
silver chloride electrode. 
RESULTS 
Substrate-independent Ion Flux-In order to test for the 
presence of substrate-independent ionic currents mediated by 
the EAAT1 and EAAT2 subtypes, the membrane conductance 
of oocytes expressing these transporters was compared with 
the conductance of uninjected oocytes in the absence of amino 
acid (Fig. lA). The chord conductance (measured between -40 
and +40 mV) in a group ofuninjected control oocytes was 1.8:!:: 
0.4 f.LS (mean :!:: S.E., n = 6). In oocytes from the same group 
that expressed EAAT2, the chord conductance was unchanged 
from control (1.9 :!:: 0.4 f.LS; n = 6), while in oocytes expressing 
comparable levels of EAAT1, this value was increased signifi-
cantly (3.4 :!:: 0.6 f.LS; n = 6; p < 0.05). Similar results were seen 
in different batches of oocytes from three frogs. Subtraction of 
the mean current-voltage relationship of uninjected oocytes 
from that of oocytes expressing EAAT1 revealed the voltage 
dependence of the uncoupled ion flux (Fig. 1B). This current 
was approximately linear over the voltage range -100 to +40 
mV and reversed at -16.9:!:: 4.9 mV (n = 8). In order to test 
whether the glutamate-independent current in oocytes ex-
pressing EAAT1 was mediated by the transporter, the differ-
ence in conductance from the controls was compared with the 
amplitude of the current elicited by 300 f.LM L-glutamate at 
-100 m V in oocytes expressing different levels of transporter. 
There was a linear correlation in individual oocytes (Fig. 1C), 
demonstrating that the amplitude of the glutamate-indepen-
dent current was related to the transporter expression level 
(r = 0.89). These results suggest that EAAT1, but not EAAT2, 
mediates a substrate-independent ion flux. 
Expression and Kinetic Parameters of a Chimeric Trans-
porter-Kainate competitively antagonizes the EAAT2-medi-
ated current induced by L-glutamate with a Kd of 14 f.LM but has 
no effect on the steady state current in the absence of gluta-
mate at membrane potentials between -160 mV and +80 mV 
(6). In contrast to EAAT2, glutamate transport by EAAT1 is 
relatively insensitive to kainate (9). Application of up to 3 mM 
kainate alone to oocytes expressing EAAT1 does not induce any 
steady-state current over this voltage range (results not 
shown). In order to further investigate the properties of the 
glutamate-independent current mediated by EAAT1 and to 
identify domains involved in the interaction of the transporter 
with kainate, chimeric transporters were constructed and as-
sessed for their kainate sensitivity. One such chimera, termed 
E1-2-1, is comprised of the EAAT1 sequence from the amino 
terminus through Ser-366 followed by the EAAT2 sequence 
through Ala-441, followed by the EAAT1 sequence through the 
carboxyl terminus (Fig. 2). E1-2-1 contains 18 residues from 
EAAT2 between Ser-366 and Ala-441 that differ from the cor-
responding EAAT1 residues. Injection of RNA transcribed from 
the E1-2-1 chimeric eDNA into oocytes resulted in a >10-fold 
increase in 3H-labeled L-glutamate uptake (data not shown). 
Application of glutamate to voltage-clamped oocytes expressing 
E1-2-1 resulted in inward currents similar to those observed in 
oocytes expressing the parent transporters (Fig. 3). The Km for 
L-glutamate exhibited by the chimeric transporter was 9 :!:: 3 
f.LM (n = 6), slightly lower than that for EAAT1 (19:!:: 3 f.LM) and 
EAAT2 (17 :!:: 2 f.LM). Because the substrate serine 0-sulfate 
displays marked differences in kinetic parameters between 
EAAT1 and EAAT2 (9), chimera-mediated currents induced by 
this compound were examined. EAAT1 displayed a Km of 35 :!:: 
2 f.LM for serine 0-sulfate and an /max (relative to glutamate) of 
1.02 :!:: 0.05, whereas the corresponding values for EAAT2 were 
237:!:: 14 f.LM and 0.54:!:: 0.02. TheKm and/max values for serine 
0-sulfate transport by E1-2-1 were 17 :!:: 3 f.LM and 1.0:!:: 0.1 (n 
= 5), suggesting that the structural domain of the chimera 
involved in determining the kinetic parameters for substrate 
translocation may be comprised of EAAT1-derived sequences. 
Kainate Actions on the Chimeric Transporter-In contrast to 
EAAT1 and EAAT2, application of kainate to oocytes express-
ing the E 1-2-1 chimeric transporter generated a small outward 
current at -60 mV (Fig. 3C). This outward current was in-
creased in a dose-dependent and saturable fashion by kainate 
(EC50 = 120 :!:: 16 f.LM at -60 mV; n = 4). In addition, co-
application of 10 f.LM glutamate with 3 mM kainate to the E1-
2-1 chimera similarly resulted in an outward current rather 
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FIG. 2. A, schematic diagram of the chimeric EAAT1/EAAT2 transporter El-2-1. Filled areas correspond to the EAATl eDNA sequence, and the 
open area corresponds to the EAAT2-derived domain inserted into EAATl (see "Experimental Procedures"). Lines above represent major 
hydrophobic domains identified using the Goldman-Engelman-Steitz algorithm (Mac Vector). B, predicted amino acid sequences of EAATl and 
EAAT2 corresponding to the substituted domain and junction region (numbers correspond to residues in EAATl). Dashes reflect identical residues 
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FIG. 3. Substitution of a block of residues from EAAT2 into 
EAATl confers kainate sensitivity to the chimeric transporter 
El-2-1. Application of kainate alone does not induce currents in 
either EAATl (top) or EAAT2 (middle), while co-application of kain-
ate with glutamate blocks the transport current mediated by EAAT2 
but not EAATl. Application of kainate alone or co-applied with glu-
tamate resulted in an outward current in cells expressing El-2-1 as 
a result of blockade of a constitutive uncoupled current in addition to 
block of the glutamate-induced current (see text). Oocytes were volt-
age clamped at -60 mV and superfused with compounds for duration 
indicated by the bars. 
than a simple block of the inward transport current as seen 
with EAAT2. The outward current induced by kainate at -60 
m V resulted from a conductance decrease due to the block of a 
constitutive inward current, as revealed by subtraction of the 
current-voltage plot in the presence of kainate from that in its 
absence (Fig. 4A). The kainate-sensitive current reversed di-
rection at -17.9:!:: 1.0 mV (n = 16) in ND96 bathing solution, 
similar to the reversal potential of the EAAT1-associated un-
coupled flux ( -16.9 :!:: 4.9 m V, Fig. lB). Thus, the small seg-
ment ofEAAT2 sequence in the E1-2-1 chimera confers sensi-
tivity of the uncoupled current to block by kainate. 
The nature of the uncoupled current through the chimeric 
transporter was examined by ion substitution experiments. 
Partial replacement of Na+ out by choline (reducing [Na+lout 
from 100.5 to 22.5 mM) caused a 38.2 :!:: 4.2 m V (n = 6) shift in 
the reversal potential, indicating that sodium ions contribute to 
the substrate-independent leak current. A plot of the reversal 
potential of the current blocked by kainate versus the loga-
rithm of the extemal sodium concentration revealed that the 
reversal shifted 58.2 mY/decade change in [Na+]0 , in accord 
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FIG. 4. A, voltage dependence of L-glutamate-independent (uncou-
pled) and L-glutamate-dependent currents mediated by the chimeric 
El-2-1 transporter. The glutamate-induced current in a representative 
oocyte was obtained by subtraction of the current-voltage curve in the 
absence ofL-glutamate from that in the presence of300 p,M L-glutamate; 
the uncoupled current (in the same cell) was obtained by subtraction of 
the current-voltage curve in the presence of 5 mM kainate from that in 
the absence of kainate. B, the kainate-sensitive leak conductance is 
carried by Na + ions. The reversal potential of the kainate-sensitive 
uncoupled currents was measured as in A using external bath solution 
(ND96) with [K+] = 0 and in which [Na+] was varied by equimolar 
substitution with choline+. The line shows least squares fit to data 
points (mean ± S.E.; n = 5) with a slope of 58.2 mV. 
with the prediction of the Nemst equation for a Na+-selective 
electrode (Fig. 4B). The monovalent cation selectivity of the 
uncoupled conductance was further studied by equimolar re-
placement of one-half the external N a+ with K+, Li +, or cho-
line. From the reversal potential shifts, the permeability se-
quence was determined to be K+ (1.64) > Na+ (1) > Li+ (0.83) 
>> choline ( <0.04). 
Substitution of Cl-out with gluconate or methanesulfonate 
had no effect on the reversal potential of the uncoupled current 
(n = 5). However, after depletion of intracellular chloride by 
16-h incubation in gluconate-substituted medium, removal of 
extracellular chloride reversibly abolished the kainate-sensi-
tive uncoupled current (n = 5). These results indicate that, 
although chloride ions are not permeant, they are required for 
expression of the uncoupled monovalent cation current. When 
measured in chloride-free conditions to abolish the leak cur-
rent, kainate blocked the inward current induced by 30 1-LM 
L-glutamate with a K; of 97 ± 18 1-LM (n = 3), similar to the 
potency observed for the inhibition of the substrate-independ-
ent leak current in the normal ND96 bath solution (126 :!:: 6 
1-LM). This result is consistent with the hypothesis that block of 
the leak conductance and glutamate transport are both medi-
ated by kainate binding at a single site on the transporter. 
DISCUSSION 
Comparison ofthe membrane conductance of control oocytes 
with oocytes expressing EAAT1 and EAAT2 suggests that 
EAAT1, but not EAAT2, mediates an ionic flux in the absence 
of glutamate. This uncoupled flux is likely to be mediated 
directly by the transporter since its amplitude is proportional 
Glutamate Transporter Ion Fluxes and Binding Domains 17671 
to the level of transporter expression as measured by the glu-
tamate-induced current. Using cDNAs encoding the human 
EAAT1 and EAAT2 subtypes, a chimeric glutamate trans-
porter was constructed that is sensitive to the EAAT2-selective 
blocker kainate. The chimeric transporter is composed predom-
inantly of EAAT1, with the EAAT2 sequence substituted be-
tween the seventh and ninth hydrophobic domains (residues 
366-441; Fig. 2). This transposed domain encompasses a 
highly conserved region among members of the glutamate 
transporter family. For example, the motif FIAQ (residues 
415-418) is conserved among the rat homologs of EAAT1 
(GLAST (18)) and EAAT2 (GLT-1 (19)), the rabbit homolog of 
EAAT3 (EAAC1 (20)), and the Escherichia coli glutamate 
transporter gltP (21). Within the chimeric sequence derived 
from EAAT2, there are 18 residues that differ from the corre-
sponding residues in EAATl. Substitution of this discrete do-
main conferred a >50-fold increase in affinity for kainate. 
However, because the affinity ofkainate is still 7-8-fold lower 
than that observed for EAAT2, it is likely that additional amino 
acid residues influence kainate sensitivity. The study of further 
chimeras in conjunction with site-directed mutagenesis will be 
required to determine the precise role of these and other resi-
dues in the interaction of kainate with the transporter. 
The kainate sensitivity of the chimeric transporter has al-
lowed identification of the glutamate-independent current as a 
flux of monovalent cations through the transporter. Substrate-
independent currents have been observed to be mediated by 
cloned sodium-dependent transporters for glucose (11), sero-
tonin (12), y-aminobutyric acid (13), dopamine (14), and phos-
phate.3 Similar to results in the present study, a sodium-de-
pendent leakage current attributed to the glutamate 
transporter(s) endogenous to salamander retinal glial cells has 
also been reported (22). The presence of uncoupled currents in 
various sodium co-transporters may provide clues about the 
structural requirements for the permeation path involved in 
translocation of large substrate molecules in addition to small 
inorganic ions. The similarity of the inhibition constants for 
kainate block of the glutamate-dependent and -independent 
currents suggests that the ions that carry the uncoupled cur-
rent are likely to permeate the same pore region of the trans-
porter as glutamate. While transporter-mediated substrate 
translocation is commonly modeled by an alternating access 
scheme (23), the permeation and possible gating mechanisms 
underlying substrate-independent ion fluxes are not well un-
derstood. The steady-state uncoupled cation conductance of the 
glutamate transporter is relatively insensitive to membrane 
3 E. Klamo and M. Kavanaugh, unpublished observations. 
potential. Nevertheless, the requirement of the cation flux for 
chloride suggests a possibility of gating, perhaps via an allos-
teric effect of chloride binding. Alternatively, interactions be-
tween cations and chloride may occur in the transporter pore as 
have been observed in a neuronal chloride channel (24). Al-
though both EAAT1 and EAAT2 mediate a chloride flux, this 
flux requires amino acid for activation (7) and is thus distin-
guished from the uncoupled cation current that occurs in the 
absence of amino acid. Further work to elucidate the molecular 
mechanisms underlying these fluxes, including localization of 
the precise residues that comprise the permeation pathway, 
will allow the construction of increasingly more detailed models 
of transport. 
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